Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs

AstraZeneca2,609 enrolled

Overview

The purpose of this study is to obtain the distribution of measurements of the intima media thickness of carotid arteries in people with high cardiovascular risk.

Study Type

INTERVENTIONAL

Allocation

Purpose

SCREENING

Enrollment

2,609

Conditions

Cardiovascular Disease

Interventions

Measurement of the Carotid Intima Media thicknessPROCEDURE

one time, radiological procedure on both sides of the neck

Blood sample testing for hs-CRPBIOLOGICAL

one time, blood sample taking

Eligibility

Sex: ALLMin age: 30 YearsMax age: 69 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Provision of signed informed consent. * Patients with at least two CVD risk factors but not on lipid-lowering agents Exclusion Criteria: * Subjects with CHD, any conditions that may affect hs-CRP levels. * Subjects on any lipid-lowering drug treatment within the last 3 months prior study entry.

Locations (19)

Research Site

Beijing, Beijing Municipality, China

Research Site

Shanghai, Shanghai Municipality, China

Research Site

Gurgaon, India

Outcomes

Primary Outcomes

Measurement of Carotid Intima Media Thickness of people with high risk of cardiovascular disease but not on lipid lowering drugs

Time frame: IIMT measurements taken only once, either on Visit 1 or Visit 2 (time gap between V1 and V2 should be less than 3 months)

Secondary Outcomes

Lipid profile of people with high risk of cardiovascular disease but not on lipid lowering drugs

Time frame: Blood sampling only once, either on Visit 1 or Visit 2 (time gap between V1 and V2 should be less than 3 months)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.